Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8096207
Reference Type
Journal Article
Title
Comparison of carvedilol and atenolol effectiveness in patients with stable effort angina
Author(s)
Martsevich, SY; Konyakhina, IP; Alimova, EV; Kutishenko, NP; Lerman, OV
Year
2001
Is Peer Reviewed?
1
Journal
Terapevticheskii Arkhiv
ISSN:
0040-3660
Volume
73
Issue
1
Page Numbers
38-41
Language
Russian
Abstract
Aim. To compare effectiveness of carvedilol - beta-adrenoblocker with vasodilating action - with atenolol which is beta-adrenoblocker having no vasodilating activity in coronary heart disease (CHD) patients with stable effort angina. Material and methods. The trial entered 28 CHD patients with a history of myocardial infarction (MI). All the patients had no contraindications to beta-adrenoblockers, had positive exercise tolerance test. After the control period of 7-10 days the patients received either carvedilol (14 patients) or atenolol (14 patients) in a mean daily dose 20.5 mg (6.25 to 50 mg) and 25.9 mg (12.5 to 100 mg), respectively, twice a day. The course of the treatment took 4 weeks. The effect was evaluated at treadmill exercise test. Results. Both drugs diminished heart rate, carvedilol was less effective in this respect. Both drugs significantly prolonged time of exercise to the anginal attack and ST depression by 1.0 mm. Side effects arose in 6 and 4 patients, respectively. Conclusion. Carvedilol and atenolol are equally effective in the treatment of stable effort angina.
Keywords
Atenolol; Carvedilol; Coronary heart disease; Effectiveness; Stable effort angina
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity